» Articles » PMID: 33589538

Intense Arm Rehabilitation Therapy Improves the Modified Rankin Scale Score: Association Between Gains in Impairment and Function

Abstract

Objective: To evaluate the effect of intensive rehabilitation on the modified Rankin Scale (mRS), a measure of activities limitation commonly used in acute stroke studies, and to define the specific changes in body structure/function (motor impairment) most related to mRS gains.

Methods: Patients were enrolled >90 days poststroke. Each was evaluated before and 30 days after a 6-week course of daily rehabilitation targeting the arm. Activity gains, measured using the mRS, were examined and compared to body structure/function gains, measured using the Fugl-Meyer (FM) motor scale. Additional analyses examined whether activity gains were more strongly related to specific body structure/function gains.

Results: At baseline (160 ± 48 days poststroke), patients (n = 77) had median mRS score of 3 (interquartile range, 2-3), decreasing to 2 [2-3] 30 days posttherapy ( < 0.0001). Similarly, the proportion of patients with mRS score ≤2 increased from 46.8% at baseline to 66.2% at 30 days posttherapy ( = 0.015). These findings were accounted for by the mRS score decreasing in 24 (31.2%) patients. Patients with a treatment-related mRS score improvement, compared to those without, had similar overall motor gains (change in total FM score, = 0.63). In exploratory analysis, improvement in several specific motor impairments, such as finger flexion and wrist circumduction, was significantly associated with higher likelihood of mRS decrease.

Conclusions: Intensive arm motor therapy is associated with improved mRS in a substantial fraction (31.2%) of patients. Exploratory analysis suggests specific motor impairments that might underlie this finding and may be optimal targets for rehabilitation therapies that aim to reduce activities limitations.

Clinical Trial: Clinicaltrials.gov identifier: NCT02360488.

Classification Of Evidence: This study provides Class III evidence that for patients >90 days poststroke with persistent arm motor deficits, intensive arm motor therapy improved mRS in a substantial fraction (31.2%) of patients.

Citing Articles

Advancing ischemic stroke diagnosis and clinical outcome prediction using improved ensemble techniques in DSC-PWI radiomics.

Yassin M, Lu J, Zaman A, Yang H, Cao A, Zeng X Sci Rep. 2024; 14(1):27580.

PMID: 39528656 PMC: 11555321. DOI: 10.1038/s41598-024-78353-y.


Improving patient outcomes in acute and subacute stroke using a wearable device-assisted rehabilitation system: a randomized controlled trial.

Ho H, Wu L, Wu E, Lee S, Lee T, Chiang S J Int Med Res. 2024; 52(10):3000605241281425.

PMID: 39387211 PMC: 11468635. DOI: 10.1177/03000605241281425.


Examination of acute spin exercise on GABA levels in aging and stroke: The EASE study protocol.

McGregor K, Novak T, Nocera J, Mammino K, Wolf S, Krishnamurthy L PLoS One. 2024; 19(7):e0297841.

PMID: 39008457 PMC: 11249249. DOI: 10.1371/journal.pone.0297841.


Electric Field Navigated 1-Hz rTMS for Poststroke Motor Recovery: The E-FIT Randomized Controlled Trial.

Edwards D, Liu C, Dunning K, Fregni F, Laine J, Leiby B Stroke. 2023; 54(9):2254-2264.

PMID: 37577801 PMC: 10453351. DOI: 10.1161/STROKEAHA.123.043164.


Telerehabilitation Initiated Early in Post-Stroke Recovery: A Feasibility Study.

Edwards D, Kumar S, Brinkman L, Ferreira I, Esquenazi A, Nguyen T Neurorehabil Neural Repair. 2023; 37(2-3):131-141.

PMID: 36876946 PMC: 10080366. DOI: 10.1177/15459683231159660.


References
1.
Weimar C, Ziegler A, Konig I, Diener H . Predicting functional outcome and survival after acute ischemic stroke. J Neurol. 2002; 249(7):888-95. DOI: 10.1007/s00415-002-0755-8. View

2.
Broderick J, Adeoye O, Elm J . Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke. 2017; 48(7):2007-2012. PMC: 5552200. DOI: 10.1161/STROKEAHA.117.017866. View

3.
Katz R . FDA: evidentiary standards for drug development and approval. NeuroRx. 2005; 1(3):307-16. PMC: 534930. DOI: 10.1602/neurorx.1.3.307. View

4.
Wolf S, Winstein C, Miller J, Taub E, Uswatte G, Morris D . Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA. 2006; 296(17):2095-104. DOI: 10.1001/jama.296.17.2095. View

5.
Rathore S, Hinn A, Cooper L, Tyroler H, Rosamond W . Characterization of incident stroke signs and symptoms: findings from the atherosclerosis risk in communities study. Stroke. 2002; 33(11):2718-21. DOI: 10.1161/01.str.0000035286.87503.31. View